Federal Council increases safety of in-vitro diagnostics
6. Mai 2022 – At its meeting on 4 May 2022, the Federal Council adopted the new Ordinance on In-vitro Diagnostic Medical Devices (Verordnung über In-vitro-Diagnostika, IvDV) and the amendment to the Ordinance on Clinical Trials with Medical Devices (Verordnung über klinische Versuche mit Medizinprodukten, KlinV-Mep). The new provisions will enter into force on 26 May 2022. They are the final stage in the adaptation of Swiss medical device law, which is being carried out to improve patient protection and to bring it into line with the new European Union regulations. These measures are also part of the federal government's master plan to strengthen biomedical research and technology.
For more information, see here.